ArticleScience China. Life sciences2026

Plant-derived CTLA-4-targeting miR152 via lipid nanoparticles potentiates doxorubicin efficacy in breast cancer immunochemotherapy.

Hanyi Ye et al.PubMed ↗Publisher ↗

No numbers read from the abstract.